Arthrosi Therapeutics

BiotechnologySeries ESan Diego, USarthrosi.com

Latest round

Series E

Last raised

Jun 2025

Total raised

$69M

Investors

9

About Arthrosi Therapeutics

Founded in 2018 by its CEO Litain Yeh, and COO Shunqi Yan and based in California, US, Arthrosi Therapeutics operates as a biotechnology drugs developer. In June 2025, Arthrosi Therapeutics, Inc.11 million post-money. The company provides biotechnology drugs for gout patients and chronic kidney disease. The company develops the first generation of urate inhibitor treatment for gout. The company's product includes AR882, which is a novel uric acid excretory agent in clinical development for the treatment of hyperuricemia in patients with gout, including those with chronic refractory gout.

Who invested in Arthrosi Therapeutics

9 investors across 2 rounds

See all investors in Arthrosi Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Jun 6, 2025

    Amount

    $61M

    Investors

    Locked

  2. Series C

    May 20, 2020

    Amount

    $8.5M

    Investors

    Locked

Questions about Arthrosi Therapeutics

Who invested in Arthrosi Therapeutics?

Arthrosi Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Arthrosi Therapeutics raised?

Arthrosi Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Arthrosi Therapeutics last raise money?

Arthrosi Therapeutics's most recent round on record is a Series E, in Jun 2025.

What does Arthrosi Therapeutics do?

Founded in 2018 by its CEO Litain Yeh, and COO Shunqi Yan and based in California, US, Arthrosi Therapeutics operates as a biotechnology drugs developer.

Where is Arthrosi Therapeutics headquartered?

Arthrosi Therapeutics is headquartered in San Diego, US.

Which VCs invest in companies like Arthrosi Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arthrosi Therapeutics's stage. Their profiles are linked below.

Raising like Arthrosi Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.